Readers curious about obesity treatment advances will find an analysis of a large clinical trial comparing a new oral therapy's implications.
Key Takeaways
- New oral pill produced greater average weight loss than oral semaglutide
- It also improved blood sugar control more than the leading oral GLP-1 therapy
- Tablet needs no refrigeration and is cheaper to manufacture, improving accessibility